Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis

Completed

Conditions: Atherosclerosis

First Posted Date: 2015-03-19

Last Posted Date: 2016-04-22

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT02393768

Locations: 🇳🇱
Radboud university medical center, Nijmegen, Netherlands

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias

Phase 3

Completed

Conditions: Angiodysplasia
Vascular Malformations
Gastrointestinal Hemorrhage
Anemia

Interventions: Drug: Octreotide

First Posted Date: 2015-03-10

Last Posted Date: 2023-05-24

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 62

Registration Number: NCT02384122

Locations: 🇳🇱
Catharina Hospital, Eindhoven, Noord-Brabant, Netherlands
🇳🇱
Gelre Hospital, Apeldoorn, Gelderland, Netherlands
🇳🇱
Elisabeth-TweeSteden Hospital, Tilburg, Noord-Brabant, Netherlands

and more 9 locations

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

Phase 4

Completed

Conditions: HIV

Interventions: Drug: Continuation of own regimen
Drug: Raltegravir

First Posted Date: 2015-03-09

Last Posted Date: 2019-01-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT02383355

Pain Predict Genetics

Recruiting

Conditions: Chronic Pain
Acute Pain

First Posted Date: 2015-03-09

Last Posted Date: 2024-04-11

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 10000

Registration Number: NCT02383342

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands

Penetration of Cefazolin Into Hepatic Cysts

Not Applicable

Completed

Conditions: Hepatic Cyst

Interventions: Other: Peripheral intravenous cannula (IVC)
Drug: cefazolin

First Posted Date: 2015-02-20

Last Posted Date: 2016-02-03

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 8

Registration Number: NCT02368015

Locations: 🇳🇱
Radboud University Nijmegen Medical Center; Department of Gastroenterology & Hepatology, Nijmegen, Gelderland, Netherlands

Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease

Phase 4

Completed

Conditions: Crohn Disease

Interventions: Drug: Omegaven 10%
Drug: Intralipid 20%

First Posted Date: 2015-01-29

Last Posted Date: 2015-11-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 6

Registration Number: NCT02349594

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands

Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

Completed

Conditions: Transplantation Infection
Hematologic Diseases
Oncology Problem
Kidney Diseases

Interventions: Procedure: blood drawing

First Posted Date: 2015-01-01

Last Posted Date: 2022-05-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 93

Registration Number: NCT02329808

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

MRI in Renal Tumors

Completed

Conditions: Renal Cell Carcinoma

Interventions: Device: Magnetic Resonance Imaging

First Posted Date: 2014-12-25

Last Posted Date: 2020-02-24

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 39

Registration Number: NCT02325921

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands

Bioequivalence of Crushed Stribild With a Normal Breakfast or With Drip Feed Compared to the Whole Tablet

Phase 1

Completed

Conditions: HIV

Interventions: Drug: Stribild
Drug: Stribild, crushed

First Posted Date: 2014-12-25

Last Posted Date: 2021-03-15

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 24

Registration Number: NCT02325934

Locations: 🇳🇱
CRCN, Radboud University Medical Center, Nijmegen, Netherlands

Liposomal Amphotericin B (AmBisome) Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ASPEN)

Phase 4

Completed

Conditions: Morbid Obesity

Interventions: Drug: Administration of study drug

First Posted Date: 2014-12-19

Last Posted Date: 2020-10-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 16

Registration Number: NCT02320604

Locations: 🇳🇱
St. Antonius hospital, Nieuwegein, Netherlands
🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy